NEW YORK (GenomeWeb) – Natera announced today that it has prices its $100 million common stock offering.
The San Carlos, California-based molecular diagnostics firm is offering 5,263,158 shares of common stock at $19 per share. Gross proceeds from the offering would be $100 million, however, the underwriters of the transaction have a 30-day option to purchase an additional 789,473 shares at the offering price.
JP Morgan, Cowen, and Piper Jaffray are acting as joint book-running managers for the offering. Baird and Canaccord Genuity are listed as co-managers for the offering.